HOME PAGE

CORPORATE PROFILE

THE M.B.E. TEAM

OUR SEARCH PROCESS

CURRENT SEARCHES

COMPLETED SEARCHES

FAVORITE LINKS

RECENT QUOTES & EVENTS

PRESS RELEASES

CONTACT US



Press Releases

Pacira Pharmaceuticals, Inc. announces the Appointments of Thomas Sluby as Vice President, Sales and Matthew Lehmann as Vice President, Marketing – Emerging Therapies

PARSIPPANY, N.J., Oct. 20, 2016 - Pacira Pharmaceuticals, Inc. (PCRX) today announced the appointment of two key individuals who will assume leadership roles within the company’s commercial organization. Thomas Sluby has been named Vice President, Sales and Matthew Lehmann has been appointed Vice President, Marketing – Emerging Therapies; both individuals will report to Robert Weiland, Chief Commercial Officer. More.


Noxilizer announces David A. Theil, Senior Vice President And CFO

Experienced Life Science Financial Executive Joins Management Team
January 26, 2016 (Baltimore, MD) Noxilizer, Inc., the company advancing a room temperature, NO2-based sterilization and decontamination process for bio-pharmaceutical and medical device manufacturers announces David A. Theil as their new Senior Vice President and Chief Financial Officer (CFO). More.


BD announces Appointment of Dr. Ellen Strahlman as Chief Medical Officer and Senior Vice President, Research & Development

Franklin Lakes, NJ (March 13, 2013) – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the appointment of Ellen Strahlman, M.D., M.H.Sc., to the newly created position of Chief Medical Officer and Senior Vice President, Research & Development, effective April 22, 2013. Dr. Strahlman will report to Chairman, CEO and President Vincent A. Forlenza and will serve as a member of the Company’s Management Committee and Leadership Team. In her new role, Dr. Strahlman will oversee the Company’s Medical Affairs and Research & Development functions. More.



MBELS STAFF:
CONTACT MBELS

Site Designed & Maintained by Susan Ivankovich Web Design